13F-HR filed by RENAISSANCE TECHNOLOGIES LLC
RENAISSANCE TECHNOLOGIES LLC filed this 13F-HR for the quarter ended 2019-06-30, filed 2019-08-12, with 3,513 holding rows worth $113,583,341,000.
- Accession
- 0001037389-19-000271
- Filer
- CIK 1037389
- Filed
- 2019-08-12
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2019
A holdings report, 3,513 entries on the cover page, a total value of $113,583,341,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $113,583,341,000 with VALUE read as thousands by filing date, 13F file number 028-06262. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| EVOKE PHARMA INC | 30049G104 | COM | 21,442 | $13,000 | thousands by filing date | |
| CHINA CERAMICS CO LTD | G2113X134 | SHS | 14,400 | $13,000 | thousands by filing date | |
| ZION OIL & GAS INC | 989696109 | COM | 35,100 | $12,000 | thousands by filing date | |
| CHESAPEAKE GRANITE WASH TRUST | 165185109 | COMMON STOCK | 10,700 | $11,000 | thousands by filing date | |
| INDUSTRIAL SVCS AMER INC FLA | 456314103 | COM | 11,200 | $11,000 | thousands by filing date | |
| AKERS BIOSCIENCES INC | 00973E300 | COM NEW | 24,650 | $11,000 | thousands by filing date | |
| URBAN TEA INC | G9396G100 | ORD SHS | 16,984 | $11,000 | thousands by filing date | |
| BENITEC BIOPHARMA LTD | 082053307 | SPONS ADR NEW | 13,700 | $10,000 | thousands by filing date | |
| NAKED BRAND GROUP LIMITED | Q6519T109 | ORD SHS | 66,700 | $9,000 | thousands by filing date | |
| China Rapid Finance Ltd ADR | 16953Q105 | ADR | 16,000 | $8,000 | thousands by filing date | |
| GEMPHIRE THERAPEUTICS INC | 36870A108 | COM | 10,000 | $8,000 | thousands by filing date | |
| PHIO PHARMACEUTICALS CORP | 71880W204 | COM | 16,477 | $6,000 | thousands by filing date | |
| NOBILIS HEALTH CORP | 65500B103 | COM | 36,364 | $5,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001037389-19-000271 | this filing | 2019-08-12 | acceptance time not in the bulk data set |